Search Results 471-480 of 17143 for nivolumab
Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...
... nivolumab in patients with solid tumors that have spread and/or cannot be removed by surgery. The following tumor types are included in this study: Non ...
About this study. This project will investigate whether the analysis of nucleic acids circulating in the blood from tumors can allow real-time monitoring of ...
... nivolumab in patients with metastatic castration-resistant prostate cancer. Invest New Drugs. 2024 Dec; 42 (6):675-684 Epub 2024 Nov 06. View PubMed; Tinsley ...
The purpose of this study is to to bring molecular risk prediction for breast cancer into the clinical arena through: the establishment of a large tissue ...
The purpose of this study is to determine whether an investigational immuno-therapy, cabiralizumab in combination with nivolumab, with or without ...
Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...
Previous treatment with pembrolizumab, nivolumab, or other programmed cell death-1 antibody (anti- PD-1) or PD-1 ligand-antibody (anti-PD-L1) agents. New ...
This randomized Phase III, multicenter, open-label study is designed to evaluate the safety and efficacy of atezolizumab in combination with carboplatin + nab- ...
Cancer that forms in the germ-fighting lymphatic system is called lymphoma. Types of lymphoma include Hodgkin lymphoma and non-Hodgkin lymphoma.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!